These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

520 related items for PubMed ID: 16140364

  • 1. Resource utilization for ovarian cancer patients at the end of life: how much is too much?
    Lewin SN, Buttin BM, Powell MA, Gibb RK, Rader JS, Mutch DG, Herzog TJ.
    Gynecol Oncol; 2005 Nov; 99(2):261-6. PubMed ID: 16140364
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis.
    Pelletier EM, Shim B, Goodman S, Amonkar MM.
    Breast Cancer Res Treat; 2008 Mar; 108(2):297-305. PubMed ID: 17577662
    [Abstract] [Full Text] [Related]

  • 5. What length of hospice use maximizes reduction in medical expenditures near death in the US Medicare program?
    Taylor DH, Ostermann J, Van Houtven CH, Tulsky JA, Steinhauser K.
    Soc Sci Med; 2007 Oct; 65(7):1466-78. PubMed ID: 17600605
    [Abstract] [Full Text] [Related]

  • 6. The cost of adjuvant chemotherapy in patients with early-stage breast carcinoma.
    Oestreicher N, Ramsey SD, McCune JS, Linden HM, Veenstra DL.
    Cancer; 2005 Nov 15; 104(10):2054-62. PubMed ID: 16216002
    [Abstract] [Full Text] [Related]

  • 7. Government expenditures at the end of life for short- and long-stay nursing home residents: differences by hospice enrollment status.
    Miller SC, Intrator O, Gozalo P, Roy J, Barber J, Mor V.
    J Am Geriatr Soc; 2004 Aug 15; 52(8):1284-92. PubMed ID: 15271115
    [Abstract] [Full Text] [Related]

  • 8. Health care utilization of patients with chronic obstructive pulmonary disease and lung cancer in the last 12 months of life.
    Goodridge D, Lawson J, Duggleby W, Marciniuk D, Rennie D, Stang M.
    Respir Med; 2008 Jun 15; 102(6):885-91. PubMed ID: 18313278
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cost-utility analysis of short- versus long-course palliative radiotherapy in patients with non-small-cell lung cancer.
    van den Hout WB, Kramer GW, Noordijk EM, Leer JW.
    J Natl Cancer Inst; 2006 Dec 20; 98(24):1786-94. PubMed ID: 17179480
    [Abstract] [Full Text] [Related]

  • 13. The effect of total parenteral nutrition on the survival of terminally ill ovarian cancer patients.
    Brard L, Weitzen S, Strubel-Lagan SL, Swamy N, Gordinier ME, Moore RG, Granai CO.
    Gynecol Oncol; 2006 Oct 20; 103(1):176-80. PubMed ID: 16564074
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The utilization of palliative care in gynecologic oncology patients near the end of life.
    Fauci J, Schneider K, Walters C, Boone J, Whitworth J, Killian E, Straughn JM.
    Gynecol Oncol; 2012 Oct 20; 127(1):175-9. PubMed ID: 22735789
    [Abstract] [Full Text] [Related]

  • 16. Aggressive and complex surgery for advanced ovarian cancer: an economic analysis.
    Aletti GD, Podratz KC, Moriarty JP, Cliby WA, Long KH.
    Gynecol Oncol; 2009 Jan 20; 112(1):16-21. PubMed ID: 19027146
    [Abstract] [Full Text] [Related]

  • 17. Patterns of high-dose morphine use in a home-care hospice service: should we be afraid of it?
    Bercovitch M, Adunsky A.
    Cancer; 2004 Sep 15; 101(6):1473-7. PubMed ID: 15368335
    [Abstract] [Full Text] [Related]

  • 18. Hospice and emergency room use by disadvantaged men dying of prostate cancer.
    Bergman J, Kwan L, Fink A, Connor SE, Litwin MS.
    J Urol; 2009 May 15; 181(5):2084-9. PubMed ID: 19286207
    [Abstract] [Full Text] [Related]

  • 19. The end of life costs for Medicare patients with advanced ovarian cancer.
    Urban RR, He H, Alfonso R, Hardesty MM, Goff BA.
    Gynecol Oncol; 2018 Feb 15; 148(2):336-341. PubMed ID: 29208368
    [Abstract] [Full Text] [Related]

  • 20. Effect of erythropoiesis-stimulating agents on healthcare utilization, costs, and outcomes in chronic kidney disease.
    Maddux FW, Shetty S, del Aguila MA, Nelson MA, Murray BM.
    Ann Pharmacother; 2007 Nov 15; 41(11):1761-9. PubMed ID: 17895328
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.